Why the signs are positive for the Alliance Pharma share price (LON:APH)

Around 90% of the world's data has been created in the last two years - so understanding the difference between what is meaningful and what is just noise is more important now than ever. Successful investors know which numbers to track and which to discard – which is more important than ever now given current market volatility.

Focusing on the figures that tell us what’s actually happening can help keep us out of trouble. At Stockopedia, we read through academic studies and backtest strategies to identify these key measures. One of the best we have found so far is the Piotroski F-Score - and the F-Score has good news for shareholders of small cap Healthcare company Alliance Pharma (LON:APH).

GET MORE DATA-DRIVEN INSIGHTS INTO LON:APH »

Why Alliance Pharma shareholders need to know the Piotroski F-Score

Those that know well-respected accounting professor Joseph Piotroski are aware of the checklist that made him famous in the early Noughties. This 'F-Score' is a simple indicator to identify neglected companies whose fortunes are changing for the better.

The Piotroski F-Score contains nine checks split up into three main areas of financial analysis. First is profitability, where it examines operating profits and cash flow to make sure the business can sustain itself and pay dividends. Then come three checks on the capital structure of a business, followed by a final look at the operating efficiency of the firm.

Interpreting Alliance Pharma's F-Score

The great thing about the F-Score is that it is essentially an entire quality and fundamental momentum screen in a single number, succinctly summing up the financial health trend of a company. Applying it as a filter on top of almost any strategy can help to increase returns and reduce risk.

Stockopedia applies algorithms to its stream of financial data to automatically calculate the Piotroski F-Score for every stock on the market. It shows that Alliance Pharma (LON:APH) scores 8 out of a possible 9.

In his landmark academic paper "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers", Piotroksi showed that by investing in companies scoring 8 or 9 by these measures over a 20-year test period through to 1996, investor returns could be increased by an astounding 7.5% each year.

Find more high-quality stocks

This F-Score suggests Alliance Pharma is a promising investment candidate and is worthy of further research - but it is only a first step. Higher F-Score stocks often trade at a premium compared to other stocks. Investors like to pay up for quality but it's important not to pay too much. We suggest checking the various value factor measures for Alliance Pharma on the group's StockReport.

For years, the Stockopedia team have been poring over studies to see what works in investing. That's how we found the F-Score, but that's not all we've found... So take a two-week free trial today to see how Stockopedia can help you to build a better portfolio.